focus -WSS

focus

author：fashion 2025-09-29 01:45:45 - browse：48217

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： A new drug could help frostbite victims avoid its ravages

WSS

Boston competes with Raleigh

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

As AI regulations shape up, health tech startups beg for clarity

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Surprise medical billing ban raises prices elsewhere

Congress may force more Covid

knowledge

focus

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

WATCH: Why do our ears pop?

Virginia high school admissions case could be legal follow

Philips to halt sales of sleep apnea machines in U.S.

Peter Hotez and the public health issue of online harassment

The Affordable Care Act has saved billions in health care costs

Trump demands the U.S. pay no more for drugs than other countries … again

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

The high cost of giving birth even with insurance

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

entertainment

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Wegovy leads to weight loss. Can it treat depression, too?

White House pharmacy plagued with problems, investigation finds

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Zyn nicotine pouches become unlikely player in latest culture war

Vertex non

leisure time

explore

entertainment

entertainment